Cryptosporidiosis Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Cryptosporidiosis Global Clinical Trials Review, H1, 2019" provides an overview of Cryptosporidiosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cryptosporidiosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Romark Laboratories LC

Johnson & Johnson

Sanofi

AbbVie Inc

Univax Biologics Inc (Inactive)

Stolle Milk Biologics Inc

Pfizer Inc

ioGenetics Inc

Farmoquimica SA

Emmes Corporation

Romark Laboratories LC

Johnson & Johnson

Sanofi

AbbVie Inc

Univax Biologics Inc (Inactive)

Stolle Milk Biologics Inc

Pfizer Inc

ioGenetics Inc

Farmoquimica SA

Emmes Corporation

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in North America 11

Top Countries Contributing to Clinical Trials in Middle East and Africa 12

Clinical Trials by G7 Countries: Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials 13

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Clinical Trials by Sponsor Type 20

Prominent Sponsors 21

Top Companies Participating in Cryptosporidiosis Therapeutics Clinical Trials 23

Prominent Drugs 25

Clinical Trial Profile Snapshots 26

Appendix 37

Abbreviations 37

Definitions 37

Research Methodology 38

Secondary Research 38

About GlobalData 39

Contact Us 39

Source 40

List of Tables

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region, 2019* 7

Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cryptosporidiosis Therapeutics, Global ...

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region, 2019* 7

Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 9

Cryptosporidiosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2019* 10

Cryptosporidiosis Therapeutics Clinical Trials, North America, Top Countries, 2019* 11

Cryptosporidiosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 12

Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 13

Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 15

Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 16

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Phase, 2019* 17

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 18

Cryptosporidiosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 19

Cryptosporidiosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 20

Cryptosporidiosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 21

Cryptosporidiosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 23

Cryptosporidiosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 25

List of Figures

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cryptosporidiosis Therapeutics, Global ...

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Region (%), 2019* 7

Cryptosporidiosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 8

Cryptosporidiosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 9

Cryptosporidiosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2019* 10

Cryptosporidiosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 12

Proportion of Cryptosporidiosis to Infectious Disease Clinical Trials, G7 Countries (%), 2019* 13

Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 15

Cryptosporidiosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 16

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 17

Cryptosporidiosis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 18

Cryptosporidiosis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 19

Cryptosporidiosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 20

Cryptosporidiosis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 21

Cryptosporidiosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 23

Cryptosporidiosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 25

GlobalData Methodology 38

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports